PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.52%
Revenue growth at 50-75% of 0354.HK's 5.28%. Martin Whitman would worry about competitiveness or product relevance.
16.18%
Positive gross profit growth while 0354.HK is negative. John Neff would see a clear operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
59.72%
Operating income growth above 1.5x 0354.HK's 31.60%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
1154.17%
Net income growth above 1.5x 0354.HK's 68.28%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
1100.00%
EPS growth above 1.5x 0354.HK's 60.82%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
1100.00%
Diluted EPS growth above 1.5x 0354.HK's 54.32%. David Dodd would see if there's a robust moat protecting these shareholder gains.
3.74%
Share reduction more than 1.5x 0354.HK's 8.24%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
3.76%
Diluted share reduction more than 1.5x 0354.HK's 8.02%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
2215.96%
Dividend growth of 2215.96% while 0354.HK is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-178.65%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-180.23%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-3.04%
Negative 10Y revenue/share CAGR while 0354.HK stands at 446.26%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
23.10%
5Y revenue/share CAGR under 50% of 0354.HK's 69.32%. Michael Burry would suspect a significant competitive gap or product weakness.
-2.31%
Negative 3Y CAGR while 0354.HK stands at 64.90%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-979.39%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-234.22%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
42.96%
Positive 3Y OCF/share CAGR while 0354.HK is negative. John Neff might see a big short-term edge in operational efficiency.
-37.41%
Negative 10Y net income/share CAGR while 0354.HK is at 348.85%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-46.65%
Negative 5Y net income/share CAGR while 0354.HK is 181.29%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
6.63%
Below 50% of 0354.HK's 156.15%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
28.42%
Below 50% of 0354.HK's 78.79%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
10.30%
Below 50% of 0354.HK's 35.19%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
-64.73%
Negative 5Y dividend/share CAGR while 0354.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-43.17%
Negative near-term dividend growth while 0354.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-100.00%
Firm’s AR is declining while 0354.HK shows 28.79%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-4.99%
Inventory is declining while 0354.HK stands at 67.28%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-4.21%
Negative asset growth while 0354.HK invests at 6.69%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.59%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-16.02%
We’re deleveraging while 0354.HK stands at 11.78%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-14.33%
We cut SG&A while 0354.HK invests at 23.21%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.